Total Payments
$16,818
2024 Payments
$2,512
Companies
55
Transactions
756
Medicare Patients
21,750
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$12,799 (76.1%)
Other$3,725 (22.1%)
Education$293.85 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,799 | 746 | 76.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,725 | 5 | 22.1% |
| Education | $293.85 | 5 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $5,599 | 107 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,094 | 168 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $976.23 | 33 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $907.74 | 60 | $0 (2023) |
| United Therapeutics Corporation | $643.09 | 15 | $0 (2024) |
| GENZYME CORPORATION | $530.57 | 21 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $469.77 | 23 | $0 (2024) |
| Genentech USA, Inc. | $400.12 | 32 | $0 (2022) |
| Insmed, Inc. | $384.92 | 25 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $360.25 | 30 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,512 | 110 | AstraZeneca Pharmaceuticals LP ($546.20) |
| 2023 | $2,180 | 110 | GlaxoSmithKline, LLC. ($414.00) |
| 2022 | $1,860 | 106 | AstraZeneca Pharmaceuticals LP ($321.85) |
| 2021 | $282.74 | 16 | Boehringer Ingelheim Pharmaceuticals, Inc. ($55.93) |
| 2020 | $348.90 | 22 | AstraZeneca Pharmaceuticals LP ($73.39) |
| 2019 | $2,111 | 143 | GlaxoSmithKline, LLC. ($315.87) |
| 2018 | $1,549 | 115 | GlaxoSmithKline, LLC. ($369.37) |
| 2017 | $5,974 | 134 | AstraZeneca Pharmaceuticals LP ($3,836) |
All Payment Transactions
756 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.08 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $0.46 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.87 | General |
| Category: Immunology | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.43 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $31.61 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Cardiology | ||||||
| 11/11/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $35.30 | General |
| Category: Immunology | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.44 | General |
| Category: Immunology | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $43.44 | General |
| Category: Respiratory | ||||||
| 10/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $19.94 | General |
| Category: HFCWO | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 5,199 | 5,622 | $1.1M | $292,387 |
| 2022 | 23 | 5,338 | 5,926 | $1.0M | $283,711 |
| 2021 | 26 | 5,767 | 6,730 | $1.2M | $335,172 |
| 2020 | 30 | 5,446 | 6,392 | $1.0M | $298,342 |
Total Patients
21,750
Total Services
24,670
Medicare Billing
$1.2M
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 662 | 820 | $196,800 | $73,609 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 847 | 945 | $155,925 | $57,439 | 36.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 257 | 257 | $93,548 | $30,992 | 33.1% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 1,018 | 1,101 | $124,413 | $29,386 | 23.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 719 | 771 | $72,078 | $17,752 | 24.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 293 | 297 | $47,271 | $12,039 | 25.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 26 | 28 | $58,493 | $11,994 | 20.5% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 286 | 291 | $43,398 | $11,494 | 26.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 20 | 20 | $40,700 | $8,755 | 21.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 101 | 101 | $23,937 | $7,461 | 31.2% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 231 | 233 | $50,333 | $5,706 | 11.3% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 139 | 139 | $49,733 | $5,659 | 11.4% |
| 31622 | Diagnostic exam of lung airway using an endoscope | Facility | 2023 | 37 | 37 | $27,824 | $3,703 | 13.3% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 42 | 42 | $24,276 | $3,691 | 15.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 31 | 31 | $4,464 | $2,141 | 48.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 73 | 73 | $11,730 | $2,057 | 17.5% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 146 | 148 | $8,140 | $1,996 | 24.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 43 | 43 | $4,257 | $1,812 | 42.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 14 | 15 | $8,970 | $1,195 | 13.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 31 | 31 | $992.00 | $867.90 | 87.5% |
| 71045 | X-ray of chest, 1 view | Office | 2023 | 40 | 46 | $3,320 | $850.49 | 25.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 81 | 85 | $595.00 | $576.24 | 96.8% |
| 82803 | Blood gases measurement | Office | 2023 | 19 | 21 | $1,974 | $536.55 | 27.2% |
| 36600 | Artery puncture collection of blood sample | Office | 2023 | 21 | 23 | $17,618 | $472.47 | 2.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 12 | $696.00 | $129.00 | 18.5% |
About Dr. Michael Marshall, MD
Dr. Michael Marshall, MD is a Pulmonary Disease healthcare provider based in West Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326026287.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Marshall, MD has received a total of $16,818 in payments from pharmaceutical and medical device companies, with $2,512 received in 2024. These payments were reported across 756 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($12,799).
As a Medicare-enrolled provider, Marshall has provided services to 21,750 Medicare beneficiaries, totaling 24,670 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location West Columbia, SC
- Active Since 01/02/2006
- Last Updated 11/09/2020
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1326026287
Products in Payments
- BEVESPI AEROSPHERE (Drug) $3,875
- DUPIXENT (Biological) $1,356
- TRELEGY ELLIPTA (Drug) $1,112
- FASENRA (Biological) $547.58
- OFEV (Drug) $446.98
- ORENITRAM (Drug) $416.88
- Arikayce (Drug) $384.92
- NUCALA (Biological) $378.35
- BREZTRI (Drug) $340.09
- ANORO (Drug) $322.27
- SYMBICORT (Drug) $290.95
- TEZSPIRE (Biological) $272.71
- GLASSIA (Biological) $242.50
- Xolair (Biological) $237.48
- TYVASO (Drug) $226.21
- UPTRAVI (Drug) $221.13
- Adempas (Drug) $220.27
- SMARTVEST (Device) $215.48
- Xyrem (Drug) $209.39
- BREO (Drug) $197.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in West Columbia
Francis Dayrit, Md, MD
Pulmonary Disease — Payments: $14,239
Pulmonary Disease $14,239
Dr. William Ghent, Md, MD
Pulmonary Disease — Payments: $14,028
Pulmonary Disease $14,028
Dr. Richard Monk, M.d, M.D
Pulmonary Disease — Payments: $2,951
Pulmonary Disease $2,951
Mr. Paul Kirschenfeld, Md, MD
Pulmonary Disease — Payments: $543.19
Pulmonary Disease $543.19
Erin Hays, Md, MD
Pulmonary Disease — Payments: $103.12
Pulmonary Disease $103.12